Navigation Links
Solazyme Testing BlueFire Ethanol Cellulosic Sugars in Its Microalgae Renewable Oil Production Process
Date:5/26/2009

IRVINE, Calif., May 26 /PRNewswire-FirstCall/ -- BlueFire Ethanol Fuels, Inc. (OTC Bulletin Board: BFRE), a company changing the world's transportation fuel paradigm through the production of ethanol from non-food cellulosic wastes, announced that Solazyme, Inc., a renewable oil production company and leading algal synthetic biology company, is testing sugars, produced through BlueFire's patented process, for compatibility with its renewable oil process to produce the oil cost effectively and at scale.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090511/BLUEFIRELOGO )

"Our technologies are a great fit for each other," stated Arnold Klann, CEO of BlueFire Ethanol Fuels, Inc. "Our patented acid hydrolysis process allows BlueFire Ethanol to utilize a variety of non-food feedstocks to produce sugars that can be used to make a variety of different types of fuels and chemicals. Supplying these low cost sugars to Solazyme's technology provides them with the option of creating a variety of oils for the renewable energy industry and beyond."

BlueFire Ethanol is currently focused on developing its first ethanol biorefinery in Lancaster, California. The Lancaster facility will use post-sorted cellulosic wastes diverted from landfills in Southern California to produce 3.9 million gallons of fuel-grade ethanol per year. The company was also awarded $40 million from the U.S. Department of Energy for construction of a second plant in Southern California, and has received the first installment of funding from the DOE for the development of the BlueFire Mecca, LLC plant in Southern California.

About Solazyme:

Solazyme, Inc. is a renewable oil production company and the leader in algal synthetic biology. Solazyme's unique microbial conversion technology process allows algae to produce oil in standard industrial facilities quickly, efficiently and at large scale. These oils are tailored not only for advanced biofuel production, but also as replacements for fossil petroleum and plant oils in a diverse range of products running from green household cleaning supplies to cosmetics and foods. The company was founded in 2003 and has its headquarters in South San Francisco, California. For more information, please visit www.solazyme.com.

About BlueFire Ethanol Fuels

BlueFire Ethanol Fuels, Inc. was established to deploy a commercially ready, patented and proven Concentrated Acid Hydrolysis Technology Process for the profitable conversion of cellulosic ("Green Waste") waste materials to ethanol, a viable alternative to gasoline. BlueFire is the only cellulose-to-ethanol company worldwide with demonstrated production of ethanol from urban trash (post-sorted MSW), rice and wheat straws, wood waste and other agricultural residues.

BlueFire is one of four ethanol companies awarded funding from the U.S. Department of Energy to construct ethanol production facilities. Unlike remote corn ethanol production plants, BlueFire's biorefineries will be located in markets with the highest demand for ethanol. This dramatically reduces delivery costs and increases biofuels supply, while providing a unique waste processing technology that helps cities better manage the problem of overflowing landfills. For more information, visit www.BlueFireEthanol.com.

Forward-Looking Statements

Statements about BlueFire Ethanol, Inc.'s expectations, including future revenues and earnings, and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as the term is defined in the Private Litigation Reform Act of 1995. BlueFire's actual results could differ materially from expected results. BlueFire undertakes no obligation to update forward-looking statements to reflect subsequently occurring events or circumstances. Should events occur which materially affect any comments made within this press release; BlueFire will appropriately inform the public.


'/>"/>
SOURCE BlueFire Ethanol Fuels, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Solazyme Announces New Senior Vice President of Business Development
2. Solazyme Selected for National Institute of Standards and Technology Award
3. Solazyme, Inc. Selected by AlwaysOn as a GoingGreen 100 Top Private Company Award Winner
4. ElutraSep Inc. Announces the Launch of the Cryptonite™ HV Filter Module for Cryptosporidium and Giardia Testing
5. Microtest Labs Adds Dissolution Testing to its Suite of Analytical and Stability Testing Services
6. University of Illinois Medical Center in Chicago First Hospital to Install Innovative Shape-HF™ Cardiopulmonary Testing System
7. First H1N1 Swine Flu Vaccine, Replikins-Based, Is Ready Now for Testing Worldwide
8. H1N1 Influenza "Swine Flu" Peptide Vaccine Now Available For Testing Worldwide
9. SeqWright Expands into the Genetically-Targeted Therapy Field by Partnering with PharmaGenoma to Provide Next-Generation Hair Loss Treatment Genetic Testing
10. Microtest Labs Expands Clean Room, Contamination Testing Services
11. EnWave Announces Collaboration and Initial Testing Results with Danisco AS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... ... February 17, 2017 , ... Academy of Model Aeronautics ... leading maker of unmanned aircraft systems (UAS), are launching a joint program to ... effectively, and support educational outreach efforts. , AMA and DJI will collaborate on ...
(Date:2/16/2017)... (PRWEB) , ... February 16, 2017 , ... Avomeen & ... The event will be held at Avomeen Analytical Services (4840 Venture Dr., Ann ... MichBio member organization. They provide an opportunity to interact with peers, make new connections ...
(Date:2/16/2017)... , Feb. 16, 2017  MDNA Life Sciences ... development of liquid biopsy tests based on the ... an exclusive license agreement with its first international ... liquid biopsy test for prostate cancer, the Prostate ... . This is the first overseas appointment ...
(Date:2/16/2017)... 16, 2017   Capricor Therapeutics, Inc. ... company developing first-in-class biological therapies for cardiac and ... elected to terminate its license agreement with the ... including Cenderitide. "Our decision to return ... prioritize our efforts to advance our core cell ...
Breaking Biology Technology:
(Date:2/3/2017)... ANTONIO , Feb. 3, 2017  Texas Biomedical Research ... Dr. Larry Schlesinger as the Institute,s new ... Texas Biomed effective May 31, 2017. He is currently the ... Director of the Center for Microbial Interface Biology at Ohio ... Schlesinger as the new President and CEO of Texas Biomed," ...
(Date:2/2/2017)... , Feb. 2, 2017   TapImmune, ... clinical-stage immuno-oncology company specializing in the development of ... the treatment of cancer and metastatic disease, announced ... and GMP manufacturing of a second clinical lot ... targeting folate receptor alpha. The manufactured vaccine product ...
(Date:2/2/2017)... -- Central to its deep commitment to honor the ... Prize Foundation today announced the laureates of the ... in their respective fields of Life Sciences and ... recognized with the 2017 Japan Prize for original ... the advancement of science and technology, but also ...
Breaking Biology News(10 mins):